DN Group AG has consistently realigned its business model towards impact investing sinc...
* Signs major IFM contract with Entra in Norway * Adds ~10% to Norway sales, ~2% on group * The cont...
VBG omsättning ökade 5,8 procent i Q3, varav 5,4 procent organiskt.
Redeye comments on EG7’s Q3-results, which were weaker than forecasted owing to a lower-than-expecte...
Xspray's Q3 release was undramatic with the primary near-term happenings relating to the ongoing FDA...
* Q3E sales up ~54% y-o-y to SEK 78m, led by defence * Adj.
Q3 was hit by EUR9.5m in special items, but order intake was strong.
Redeye updates on Better Collective ahead of Q3-results (due 18 November).
Premium Snacks levererade ett starkt Q3’26 med en tillväxt om 18,1 % till 171,4 MSEK, bolagets högst...
Accelererande tillväxt och stark operativ hävstång Bruttoresultatet ökade med 25,3 % till 67,7 MSEK...
Redeye provides an update on Ascelia after the company’s Q3 report, which held few surprises.
Redeye reviews CSG following its Q2 2026/2027 report, which came in below our expectations on both t...
Sustainion redovisade en fortsatt stark organisk tillväxt i Q3’26 och en förbättrad marginal jämfört...
Redeye provides its review of Acarix following the release of the Q3 report, which showed revenue ah...
* BTS wins new AI enablement projects at scale... * .
EndoDrill GI was used in its first patient cases in Spain, while BiBB received SEK1.
Ferroamp’s Q3 report was broadly in line with our expectations, with net sales of SEK58.
Redeye comments on q.beyond's Q3 2026 report, where EUR9.
Redeye leaves its Base Case unchanged at SEK21 after marginal estimate changes.
Redeye leaves its Base Case unchanged at SEK8.2 as higher sales estimates offset slightly lower EBIT...